BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3492827)

  • 21. [Cancer and Crohn's disease].
    Winkler R; Wittmer A; Heusermann U
    Z Gastroenterol; 2002 Aug; 40(8):569-76. PubMed ID: 12297980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Colonic Crohn's disease: diagnostic and therapeutic problems. Apropos of 11 cases].
    Delavierre P; Bourdais JP; Letailleur M; Hureau J; Vayre P; Roux M
    Sem Hop; 1976 May; 52(20):1195-1206. PubMed ID: 189397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Free cecum perforation with peritonitis as a rare complication of Crohn disease].
    Kreisköther E; Arbogast R; Lehmann L; Kirchner T
    Leber Magen Darm; 1985 May; 15(3):121-4. PubMed ID: 4021697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognosis of inflammatory bowel disease.
    Sales DJ; Kirsner JB
    Arch Intern Med; 1983 Feb; 143(2):294-9. PubMed ID: 6824395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxic dilatation and perforation in inflammatory bowel disease.
    Schofield PF
    Ann R Coll Surg Engl; 1982 Sep; 64(5):318-20. PubMed ID: 7114766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surgical therapy of Crohn disease and ulcerative colitis in childhood].
    Würfel A; Waag KL; Hofmann-von Kap-herr S
    Langenbecks Arch Chir Suppl Kongressbd; 1991; ():124-8. PubMed ID: 1793897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study.
    Goldacre MJ; Wotton CJ; Yeates D; Seagroatt V; Jewell D
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):297-304. PubMed ID: 18334873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.
    Greenstein AJ; Panvelliwalla DK; Katz LB; Heimann TM; Donnelly J; Pertsimlidis D; Geller S; Smith H; Aufses AH
    Am J Gastroenterol; 1982 Apr; 77(4):212-5. PubMed ID: 7072691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiating small bowel Crohn's disease from lymphoma. Role of rectal biopsy.
    Hyams JS; Goldman H; Katz AJ
    Gastroenterology; 1980 Aug; 79(2):340-3. PubMed ID: 7399239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathology of ulcerative colitis and granulomatous colitis (Crohn's disease), with special reference to their differences].
    Wakasa H
    Nihon Rinsho; 1977 May; 35(5):1821-7. PubMed ID: 560525
    [No Abstract]   [Full Text] [Related]  

  • 32. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
    Strugala V; Dettmar PW; Pearson JP
    Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term follow-up of Crohn disease].
    Stetter M; Schuster E; Knoflach P
    Z Gastroenterol; 1992 Jul; 30(7):454-8. PubMed ID: 1509784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surgical treatment of Crohn's disease complications. Our experience].
    Fornaro R; Secco GB; Picori E; Stabilini C; Frascio M; Ricci B; Mandolfino F; De Salvo L; Gianetta E
    G Chir; 2006; 27(1-2):21-6. PubMed ID: 16608628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative aspects of Crohn disease and ulcerative hemorrhagic rectocolitis].
    Rocco B; Pinto E; De Stefano A
    Minerva Med; 1982 Oct; 73(38):2561-78. PubMed ID: 6750448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Indications for different collagen metabolism in Crohn disease and ulcerative colitis].
    Matthes H; Stallmach A; Matthes B; Herbst H; Schuppan D; Riecken EO
    Med Klin (Munich); 1993 Apr; 88(4):185-92. PubMed ID: 8492773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Malignant changes in ulcerative colitis and Crohn's disease].
    Muto T; Konishi F; Kamiya J
    Nihon Rinsho; 1981 May; 39(5):2067-74. PubMed ID: 7026833
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathologic anatomy of ulcero-hemorrhagic rectocolitis].
    Martin ED; Marche C; Potet F; Alaoui A
    Actual Hepatogastroenterol (Paris); 1968; 4(3):A165-89. PubMed ID: 5305310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.